Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

‘Take the Pill, It Is Only Fair’! Contributory Fairness as an Answer to Rose’s Prevention Paradox

‘Take the Pill, It Is Only Fair’! Contributory Fairness as an Answer to Rose’s Prevention Paradox One proposal to significantly reduce cardiovascular disease is the idea of administering a ‘polypill’—a combination of drugs that reduce the risk of heart disease and carry few side effects—to everyone over the age of 55. Despite their promise, population strategies like the polypill have not been well-accepted. In this article, I defend the polypill (and consequently, other similar population strategies) by appealing to fairness. The argument focuses on the need to fairly distribute the costs to individuals. While the fact that population strategies like the polypill impose minor costs on everyone has primarily been used to criticize such strategies, I argue that it gives us a reason to support them. I argue that implementing a population strategy with the polypill contributes to the public good of ‘health system capacity’. I then explain that public goods have widely accepted obligations: they carry an obligation to fairly distribute the costs of the goods and prevent free-riding. Thus, we have at least one pro tanto moral reason to implement the polypill. As such, this article challenges the current literature on the topic, which has largely held adopting population strategies like the polypill to be unjustifiable. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Public Health Ethics Oxford University Press

‘Take the Pill, It Is Only Fair’! Contributory Fairness as an Answer to Rose’s Prevention Paradox

Zameska, Jay A
Public Health Ethics , Volume 14 (3): 12 – Aug 10, 2021
Download PDF
12 pages

Loading next page...
 
/lp/oxford-university-press/take-the-pill-it-is-only-fair-contributory-fairness-as-an-answer-to-cnxvQQPu2y

References (44)

Publisher
Oxford University Press
Copyright
© The Author(s) 2021. Published by Oxford University Press. Available online at www.phe.oxfordjournals.org
ISSN
1754-9973
eISSN
1754-9981
DOI
10.1093/phe/phab022
Publisher site
See Article on Publisher Site

Abstract

One proposal to significantly reduce cardiovascular disease is the idea of administering a ‘polypill’—a combination of drugs that reduce the risk of heart disease and carry few side effects—to everyone over the age of 55. Despite their promise, population strategies like the polypill have not been well-accepted. In this article, I defend the polypill (and consequently, other similar population strategies) by appealing to fairness. The argument focuses on the need to fairly distribute the costs to individuals. While the fact that population strategies like the polypill impose minor costs on everyone has primarily been used to criticize such strategies, I argue that it gives us a reason to support them. I argue that implementing a population strategy with the polypill contributes to the public good of ‘health system capacity’. I then explain that public goods have widely accepted obligations: they carry an obligation to fairly distribute the costs of the goods and prevent free-riding. Thus, we have at least one pro tanto moral reason to implement the polypill. As such, this article challenges the current literature on the topic, which has largely held adopting population strategies like the polypill to be unjustifiable.

Journal

Public Health Ethics – Oxford University Press

Published: Aug 10, 2021

There are no references for this article.